日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

CD4(+)CXCL13(+) exhausted T cells drive immune microenvironment divergence in synchronous double primary lung adenocarcinoma with different degrees of invasiveness.

CD4(+)CXCL13(+)耗竭的T细胞驱动不同侵袭程度的同步双原发性肺腺癌的免疫微环境分化。

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-1-1489
Chen Xueyu, Zhang Jiahao, Lu Tong, Du Mingyuan, Li Fangyuan, Dong Dong, Cao Yuqin, Zhang Yajie, Li Hecheng
肿瘤
T细胞
肿瘤免疫
CXCL1
CXCL13
T细胞
细胞生物学
CD4
免疫/内分泌
发表日期：2026
文献求助 收藏

Clinical-Radiomics Signature Predicts Pathologic Complete Response After Neoadjuvant Therapy in Oesophageal Squamous Cell Carcinoma

临床放射组学特征预测食管鳞状细胞癌新辅助治疗后的病理完全缓解

期刊:Interdisciplinary Cardiovascular and Thoracic Surgery
影响因子:1.3
doi:10.1093/icvts/ivag024
Shi, Liqiang; Wang, Xipeng; Chen, Xueyu; Cao, Yuqin; Li, Chengqiang; Bai, Yaya; Cheng, Zenghui; Dong, Dong; Chen, Xiaoyan; Zhang, Yajie; Li, Hecheng
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Preoperative pembrolizumab (anti-PD-1 antibody) combined with chemoradiotherapy for esophageal squamous cell carcinoma: a phase 1/2 trial (PALACE-2)

术前帕博利珠单抗（抗PD-1抗体）联合放化疗治疗食管鳞状细胞癌：一项1/2期试验（PALACE-2）

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02477-4
Li, Chengqiang; Han, Yichao; Zhao, Shengguang; Kang, Xiaozheng; Zheng, Yuyan; Cao, Yuqin; Yan, Yan; Shi, Liqiang; Wang, Xipeng; Lu, Tong; Zou, Guowen; Li, Huan; Che, Jiaming; Xiang, Jie; Zhu, Lianggang; Hang, Junbiao; Zhang, Yajie; Jin, Runsen; Han, Dingpei; Chen, Xueyu; Jing, Hui; Guo, Wei; Cheng, Zenghui; Zhao, Liqin; Chen, Xiaoyan; Yu, Bentong; Li, Jian; Li, Bin; Li, Yin; Li, Hecheng
细胞生物学
肿瘤
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏

Circulating tumor DNA as a biomarker for progression and survival in esophageal cancer after neoadjuvant therapy and esophagectomy: a systematic review and meta-analysis

循环肿瘤DNA作为食管癌新辅助治疗和食管切除术后进展和生存的生物标志物：系统评价和荟萃分析

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000003017
Shen, Tianzheng; Li, Tiancheng; Cao, Yuqin; Zhang, Yajie; Li, Hecheng
食管癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Ultra-short-period perioperative pulmonary rehabilitation on short-term outcomes after surgery in smoking patients with lung cancer: a randomized clinical trial

超短期围手术期肺康复对吸烟肺癌患者术后短期疗效的影响：一项随机临床试验

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000001856
Han, Dingpei; Wang, Xinyi; Sun, Xin; Cao, Yuqin; Li, Chengqiang; Guo, Wei; Hu, Yanxia; Hang, Junbiao; Li, Jian; Xie, Qing; Li, Hecheng
肺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Integrative analysis reveals prognostic value of cuproptosis and copper hemostasis related genes in immunotherapy for non-small cell lung cancer.

综合分析揭示了铜凋亡和铜稳态相关基因在非小细胞肺癌免疫治疗中的预后价值。

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-025-01138-7
Dong Dong, Wang Yaxin, Lu Tong, Han Yichao, Shi Liqiang, Cao Yuqin, Zhang Jiahao, Zhang Yajie, Li Hecheng
肺癌
细胞生物学
凋亡
发表日期：2025
文献求助 收藏

Physiology-Related Variations in the Blood Hormone and Metabolome of Endangered Hog Deer (Axis porcinus)

濒危豚鹿（Axis porcinus）血液激素和代谢组的生理相关变化

期刊:Metabolites
影响因子:3.7
doi:10.3390/metabo15020126
Wen, Juan; Zhao, Bo; Cao, Yuqin; Qu, Yu; Chang, Liming; Mao, Jie; Li, Yufei; Ni, Ruoyao; Zhai, Runliang; Jiang, Jianping; Zhu, Wei; Liu, Xuanzhen
代谢
免疫/内分泌
发表日期：2025
文献求助 收藏

Impact of coronavirus disease 2019 on surgery in patients with early-stage lung cancer: the COVIDLungSurg prospective cohort study

2019冠状病毒病对早期肺癌患者手术的影响：COVIDLungSurg前瞻性队列研究

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2024-1276
Niu, Zhenyi; Zhu, Feng; Cao, Yuqin; Luo, Congcong; Liu, Dan; Wang, Chunping; Qiu, Zhenbin; Peng, Lishan; Du, Mingyuan; Jin, Runsen; Yan, Yan; Dong, Dong; Jing, Hui; Wang, Xiaofeng; Guo, Wei; Guo, Zengya; Li, Chengqiang; Han, Dingpei; Zhang, Yajie; Xiang, Jie; Du, Hailei; Chen, Kai; Yin, Zhengxin; Yang, Jie; Zhong, Wenzhao; Zhou, Yongxin; Wang, Mingsong; Ma, Dongchun; Li, Hecheng
微生物学
肺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)

采用免疫疗法（Adebrelimab）联合化疗（XELOX）治疗可切除食管胃交界处腺癌的围手术期疗效：单中心、开放标签研究方案（AEGIS试验，新辅助免疫化疗）

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-13589-z
Li, Yingyi; Cao, Yuqin; Wang, Xipeng; Li, Chengqiang; Zhao, Liqin; Li, Hecheng
肿瘤
肿瘤免疫
LOX
免疫/内分泌
发表日期：2025
文献求助 收藏

Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3)

新辅助卡瑞利珠单抗联合放化疗和观察等待策略与新辅助放化疗后手术治疗局部晚期食管鳞状细胞癌的比较：一项随机对照试验的研究方案（PALACE-3）

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2024-093538
Wang, Xipeng; Li, Chengqiang; Cao, Yuqin; Kang, Xiaozheng; Leng, Xuefeng; Zheng, Yan; Zheng, Bin; Guo, Wei; Jing, Hui; Han, Yongtao; Chen, Chun; Li, Yin; Li, Hecheng
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏